CRYO SAVE GROUP : -Save Group N.V. - Appointment of Ms. Karin Dorrepaal as Non-Executive Director
05/22/2012| 01:05am US/Eastern
Recommend:
Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading international stem cell storage company and the largest family stem cell bank in Europe, is happy to welcome Ms. Karin Dorrepaal, PhD, MBA as its new Non-Executive Director.
Ms. Dorrepaal has been appointed at Cryo-Save's Annual General Meeting held on May 16, 2012.
After obtaining her PhD in medicine at the Free University of Amsterdam on a study executed in the Netherlands Cancer Institute and earning an MBA, she joined Booz Allen & Hamilton (now Booz & Co.) to become Vice President focusing on the pharmaceutical industry and advising clients on issues regarding strategy, sales, marketing and supply chain. Subsequently she served on the Executive Board of Schering AG in Berlin, where she was responsible for the Diagnostic Imaging business (turnover EUR 1,3 billion) as well as for supply chain and procurement. With her broad experience and strong external network within the industry, Ms. Dorrepaal will be a valuable addition to the Cryo-Save Board of Directors.
Ms. Dorrepaal served as a Non-Executive Director on the corporate boards of Ergo Versicherungsgruppe AG and the Hogeschool van Amsterdam/ University of Amsterdam. Currently she serves as a Non-Executive Director of MDxHealth SA in Belgium, as a member of the Triton Private Equity Industry Board in Frankfurt and as a member of the Supervisory Board of Gerresheimer AG in Düsseldorf.
Arnoud van Tulder, Chief Executive Officer, commented: "I am very glad to welcome Ms. Dorrepaal as a new Non-Executive Director. Her solid international experience will be an important asset to the Board in its continuous guidance and supervision of the strategic development of Cryo-Save."
Enquiries:
| Cryo-Save Group | + 31 (0) 575 548 998 |
| Arnoud van Tulder, Chief Executive Officer | |
| | |
| SPJ Financiële Communicatie (The Netherlands) | +31 (0)20 647 8181 |
| Kees Jongsma/Leon Melens | |
| Daniel Stewart & Company plc (UK) | + 44 (0) 20 7776 6550 |
| Martin Lampshire | |
| | |
| College Hill (UK) | + 44 (0) 20 7457 2020 |
| Rozi Morris/ Adrian Duffield | |
Free footage is available on www.videobankonline.com:
http://www.videobankonline.com/
About Cryo-Save (www.cryo-save.com/group:
http://www.cryo-save.com/group)
Cryo-Save, the leading international family stem cell bank, stores more than 200,000 samples from umbilical cord blood, cord tissue and adipose tissue. There are already many diseases treatable by the use of stem cells, and the number of treatments will only increase. Driven by its international business strategy, Cryo-Save is now represented in over 40 countries on 3 continents, with ultra-modern processing and storage facilities in Belgium, Germany, Dubai, India, South Africa and France (validation in progress).
Click here for full press release in PDF:
http://hugin.info/143308/R/1613603/513882.pdf
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: Cryo-Save Group N.V. via Thomson Reuters ONE
HUG#1613603
Recommend :
